tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market
AKTX
Akari Therapeutics
RESEARCH TOOLSreports

Akari Therapeutics (AKTX) Income Statement

350 Followers

Akari Therapeutics Income Statement

Last quarter (Q4 2025), Akari Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Akari Therapeutics's net income was $-5.30M. See Akari Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 17.27M$ 21.64M$ 16.81M$ 23.09M$ 17.21M
Depreciation and Amortization
$ 0.00$ 14.00K$ 4.00K$ 4.00K$ 4.13K
EBITDA
$ -17.27M$ -19.53M$ -16.80M$ -23.08M$ -17.21M
Operating Income
$ -17.27M$ -21.64M$ -16.81M$ -23.09M$ -17.21M
Other Income/Expenses
$ -1.03M$ 1.85M$ 6.80M$ 5.34M$ -210.10K
Pretax Income
$ -18.30M$ -19.79M$ -10.01M$ -17.75M$ -17.42M
Net Income
$ -17.30M$ -19.79M$ -10.01M$ -17.75M$ -17.42M
Per Share Metrics
Basic EPS
$ -24.00$ -66.40$ -8.00$ -8.80$ -32.80
Diluted EPS
$ -24.00$ -66.40$ -8.00$ -8.80$ -32.80
Weighted Average Shares Outstanding
 841.60K 298.60K 122.36K 78.04K 53.65K
Weighted Average Shares Outstanding (Diluted)
 841.60K 298.60K 122.36K 78.04K 53.65K
Currency in USD

Akari Therapeutics Earnings and Revenue History